Répertoire des subventions financées

Filtrer par

833 ésultat(s) trouvé(s)

Optimizing interpersonal light touch instructions to improve standing balance: Examining the impact of different instructions on postural sway and its underlying neural mechanisms

  • Type de subvention

    Team grants

  • Domaine de recherche

    Central Nervous System

  • Disease Area

    Other

  • Compétition

    2025-2026 Solutions Program Innovation + Impact Grants

  • Province

    Saskatchewan

  • Date de Début

    2026

  • Montant total du financement

    $50,000

  • Contribution Santé Canada

    $25,000

Aperçu du projet

This research explores how lightly touching another person, called interpersonal light touch (IPLT), can help people stay balanced while standing. Falls are a major health concern, especially for older adults and those with conditions like Parkinson’s disease. Previous studies show that lightly touching an object or another person adds sensory…

Preclinical assessment of a small molecule to treat neurodegeneration and inhibit disability in multiple sclerosis

  • Type de subvention

    Team grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    Multiple Sclerosis

  • Compétition

    2025-2026 Solutions Program Innovation + Impact Grants

  • Province

    Saskatchewan

  • Date de Début

    2026

  • Montant total du financement

    $150,000

  • Contribution Santé Canada

    $75,000

Aperçu du projet

Canada has one of the highest rates of MS in the world, with treatment costing an estimated $2 billion per year by 2031. Even with modern treatments, persons living with MS accumulate long-term neurological disability over time. We discovered a protein called A1 that malfunctions in the nerve cells of…

Evaluating an AI-Driven Mental Health App (LifeLine) in Northern Communities: A Randomized Controlled Trial

  • Type de subvention

    Team grants

  • Domaine de recherche

    Mental Health

  • Disease Area

    Mental illness

  • Compétition

    2025-2026 Solutions Program Innovation + Impact Grants

  • Province

    Saskatchewan

  • Date de Début

    2026

  • Montant total du financement

    $150,000

  • Contribution Santé Canada

    $75,000

Aperçu du projet

Many people in northern and Indigenous communities in Saskatchewan face challenges in accessing mental health support due to distance, limited services, and long wait times. This project aims to work together with community members, Elders, youth, and local health workers to strengthen mental health support using a mobile app that…

Customizing HELP (the Health Education and Learning Platform) to Improve Self-Management for People Living with Chronic Pain and FASD

  • Type de subvention

    Team grants

  • Domaine de recherche

    Central Nervous System

  • Disease Area

    Other

  • Compétition

    2025-2026 Solutions Program Innovation + Impact Grants

  • Province

    Saskatchewan

  • Date de Début

    2026

  • Montant total du financement

    $150,000

  • Contribution Santé Canada

    $75,000

Aperçu du projet

Managing chronic health conditions like chronic pain and Fetal Alcohol Spectrum Disorder (FASD) can be challenging, especially when support is limited. Our team has developed a mobile app called HELP (Health Education and Learning Platform) to support people in managing their health. Originally designed for transplant patients, HELP offers features…

Neuromodulation of the posterior hypothalamus as a potential novel therapy for drug-resistant temporal lobe epilepsy

  • Type de subvention

    Team grants

  • Domaine de recherche

    Central Nervous System

  • Disease Area

    Epilepsy

  • Compétition

    2025-2026 Solutions Program Innovation + Impact Grants

  • Province

    Saskatchewan

  • Date de Début

    2026

  • Montant total du financement

    $150,000

  • Contribution Santé Canada

    $75,000

Aperçu du projet

Epilepsy is a severe neurological disorder that affects approximately 300,000 Canadians. Temporal lobe epilepsy is the most common form of epilepsy in adults and is characterized by seizures that cause abnormal sensations, impaired consciousness, and loss of motor control. Anti-seizure medications are the main treatment strategy for patients with epilepsy,…